Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001445710-26-000003
Filing Date
2026-03-26
Accepted
2026-03-26 17:32:01
Documents
2
Period of Report
2026-03-25

Document Format Files

Seq Description Document Type Size
1 form3-03262026_090357.html 3  
1 form3-03262026_090357.xml 3 1869
2 ex24-03262026_090358.htm EX-24 5354
  Complete submission text file 0001445710-26-000003.txt   8749
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Issuer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4350 EXECUTIVE DRIVE, SUITE 325 SAN DIEGO CA 92121
Business Address
Andrews Patricia S (Reporting) CIK: 0001445710 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-20859 | Film No.: 26799616